BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 30027847)

  • 1. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
    Gupta A; Kumar V; Aparoy P
    Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
    Nandi S; Bagchi MC
    Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore modelling, atom-based 3D-QSAR generation and virtual screening of molecules projected for mPGES-1 inhibitory activity.
    Misra S; Saini M; Ojha H; Sharma D; Sharma K
    SAR QSAR Environ Res; 2017 Jan; 28(1):17-39. PubMed ID: 28094550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Structure-Activity Relationships of Aquatic Narcosis: A Review.
    Adhikari C; Mishra BK
    Curr Comput Aided Drug Des; 2018; 14(1):7-28. PubMed ID: 28699497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: anticancer drug design by computed descriptors.
    Nandi S; Bagchi MC
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):937-48. PubMed ID: 19555178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
    Xia Z; Yan A
    Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E
    Shekfeh S; Çalışkan B; Fischer K; Yalçın T; Garscha U; Werz O; Banoglu E
    ChemMedChem; 2019 Jan; 14(2):273-281. PubMed ID: 30537167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
    Roy K; Roy PP
    Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation.
    AbdulHameed MD; Hamza A; Liu J; Huang X; Zhan CG
    J Chem Inf Model; 2008 Jan; 48(1):179-85. PubMed ID: 18052142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR and molecular docking studies of lethal factor protease inhibitors against
    Saxena M; Nandi S; Saxena AK
    SAR QSAR Environ Res; 2019 Oct; 30(10):715-731. PubMed ID: 31556709
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
    Ahmadinejad N; Shafiei F
    Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.
    Koeberle A; Laufer SA; Werz O
    J Med Chem; 2016 Jul; 59(13):5970-86. PubMed ID: 26791385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
    Roy PP; Roy K
    J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel microsomal prostaglandin E
    Lauro G; Manfra M; Pedatella S; Fischer K; Cantone V; Terracciano S; Bertamino A; Ostacolo C; Gomez-Monterrey I; De Nisco M; Riccio R; Novellino E; Werz O; Campiglia P; Bifulco G
    Eur J Med Chem; 2017 Jan; 125():278-287. PubMed ID: 27688183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
    Mitra I; Saha A; Roy K
    J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-MoRSE descriptors explained.
    Devinyak O; Havrylyuk D; Lesyk R
    J Mol Graph Model; 2014 Nov; 54():194-203. PubMed ID: 25459771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.